Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

Author(s):: Reuter, U.; Goadsby, P.J.; Lanteri-Minet, M.; Wen, S.H.; Hours-Zesiger, P.; Ferrari, M.D. (0000-0001-9691-9449); Klatt, J.

Published: 2018
Publication type: Article / Letter to editor

Date issued: 2018-11-24
Language: English
Is part of: Lancet (2018), Vol. 392, no. 10161, p. 2280-2287
hdl: 1887/95793
doi: 10.1016/S0140-6736(18)32534-0